Business / Finance

RSS

PromoCell's New GMP Certification - EXCiPACT

In this interview, News-Medical talks to Dr. Irma Börcsök (CEO of PromoCell) and Dörte Keimer (Head of Quality Assurance) about PromoCell, the work they do and the latest GMP certification the company has achieved - EXCiPACT.

From PromoCell 21 Jan 2021

Advion announces appointment of Dr. Kaveh Kahen as new CEO David B. Patteson remains as group Chairman

Advion, Inc. announces that Dr. Kaveh Kahen will immediately become CEO of the Advion group. Dave Patteson, the prior Chairman and CEO of the group will remain as group Chairman.

From Advion 19 Nov 2020

Ziath Supports Local Food Charity

Ziath has announced support for their local food bank charity in Cambridge, UK. Famous as a centre of elite learning and high-tech industry, Cambridge also has areas of high social deprivation.

From Ziath Ltd 3 Nov 2020

Bruker introduces Vutara™ VXL best-in-class super-resolution microscope and spatial biology analysis capabilities

Bruker Corporation today announced the release of the Vutara VXL Super-Resolution Fluorescence Microscope for nanoscale biological imaging. The new system opens an affordable and easy-to-use path for both core facilities and individual investigators to enter the world of super-resolution imaging by incorporating Bruker’s industry-leading single-molecule localization (SML) technology in a streamlined system with compact footprint.

From Bruker Nano Surfaces and Metrology 23 Oct 2020

Bedfont virtually opens first overseas office in Austria

On 3rd September, Bedfont hosted a virtual launch party to open their first overseas office, Bedfont GmbH, based in Salzburg, Austria. Earlier this year Bedfont announced the acquisition of its former distributor, Dr Lahner Medizintechnik, which now serves as the new GmbH headquarters.

From Bedfont® Scientific Ltd 23 Oct 2020

A breakthrough for rapid screening: Be among the first to experiment with Restek coated blade spray technology!

Restek coated blade spray (CBS) technology accelerates rapid-screening analyses to a new level of efficiency and speed. Based on strong sample extraction and ionization foundations, CBS technology bridges the gap between sample preparation and MS/MS analysis by providing a product that can go directly from the sample to the mass spectrometer.

From Restek Corporation 21 Oct 2020

Ortho announces new appointiments to Board of Directors

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that David B. Perez, an accomplished global medical device industry veteran, has been appointed as an independent member to its Board of Directors.

From Ortho-Clinical Diagnostics, Inc. 3 Sep 2020

Nanotronics forms new subsidiary, Nanotronics Health, LLC, to accelerate innovation in the medical device industry

Nanotronics today announced the formation of Nanotronics Health, LLC, a healthcare technology company whose mission is to create urgently needed medical devices that are accessible, affordable, easy to use, and intelligently designed.

From Nanotronics 7 Aug 2020

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus, a leading manufacturer of high-end research microscopes, and Cytosurge, a precision manufacturer of cell manipulation technologies, have entered a co-marketing agreement to become a complete system provider to the scientific community’s growing need for next-generation single-cell and CRISPR genetic manipulation solutions.

From Evident Corporation - Life Sciences 24 Jul 2020

Stäubli introduces CombiTac direqt

For years, Stäubli Electrical Connectors has been successfully providing a range of connector solutions that combine high-quality power, signal, data, pneumatic and fluid connections in a single modular connector system known as CombiTac.The CombiTac system offers customers worldwide a compact and space-saving modular connector solution that can be adapted and customized to meet exact dimensional and technical requirements, and guarantees a safe and steady performanceeven under the most demanding mechanical and environmental conditions.

From Stäubli 24 Jul 2020

Analytik Jena Web Weeks – Analytik Jena launches new web seminar series for biomolecular applications, lab automation, and liquid handling

Analytik Jena is launching its brand new, English-language web seminar series “Analytik Jena Web Weeks” starting July 29, 2020. Until the end of the year, application specialists and product experts from Analytik Jena will present methods, technology solutions, and tips and tricks to make everyday laboratory work more efficient. Topics range from nucleic acid extraction, PCR, qPCR to liquid handling and laboratory automation.

From Analytik Jena US 23 Jul 2020

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases with unmet clinical need, today announced closing of an oversubscribed seed financing.

23 Jul 2020

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

British Patient Capital announces a cornerstone commitment of $65m to SV Health Investors’ latest fund, SV7 Impact Medicine Fund, to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases.

21 Jul 2020

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK’s innovation agency.

From Sphere Bio 20 Jul 2020

Olympus scanR high-content screening station v. 3.2 brings improved image quality with award-winning X Line objectives

The scanR high-content screening (HCS) station version 3.2 delivers improved image quality, better quantitative data, support for challenging segmentation and classification applications and increased speed to help life science researchers maximize the information they get from their samples.

From Evident Corporation - Life Sciences 20 Jul 2020

Business / Finance

PromoCell's New GMP Certification - EXCiPACT

Advion announces appointment of Dr. Kaveh Kahen as new CEO David B. Patteson remains as group Chairman

Ziath Supports Local Food Charity

Bruker introduces Vutara™ VXL best-in-class super-resolution microscope and spatial biology analysis capabilities

Bedfont virtually opens first overseas office in Austria

A breakthrough for rapid screening: Be among the first to experiment with Restek coated blade spray technology!

Ortho announces new appointiments to Board of Directors

Nanotronics forms new subsidiary, Nanotronics Health, LLC, to accelerate innovation in the medical device industry

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Stäubli introduces CombiTac direqt

Analytik Jena Web Weeks – Analytik Jena launches new web seminar series for biomolecular applications, lab automation, and liquid handling

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Olympus scanR high-content screening station v. 3.2 brings improved image quality with award-winning X Line objectives

NanoSurface Biomedical is now Curi Bio

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

CMA levies fines of £2.3m and secures £8m for NHS in pharma probe

Economic stimulus meaningless without the public feeling safe: New research shows two-thirds feel safer with masks

Purdue-affiliated medical device company raises over $1.5 million to scale up business

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News